Genome-wide methylation analyses in glioblastoma multiforme

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Lai, Rose K ^a   Chen, Yanwen ^b   Guan, Xiaowei ^b   Nousome, Darryl ^a   Sharma, Charu ^c   Canoll, Peter ^c   Bruce, Jeffrey ^c   Sloan, Andrew E ^d   Cortes, Etty ^c   Vonsattel, Jean Paul ^c   Su, Tao ^c   Delgado Cruzata, Lissette ^c   Gurvich, Irina ^c   Santella, Regina M ^c   Ostrom, Quinn ^b   Lee, Annette ^e   Gregersen, Peter ^e   Barnholtz Sloan, Jill ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c Department of Radiation Oncology Columbia University ^*  (United States)

^d UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^e NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROMETHYLDEOXYCYTIDINE; 5 METHYLDEOXYCYTIDINE; CYTIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EMBRYONIC STEM CELL; FEMALE; GENE FUNCTION; GENE REGULATORY NETWORK; GENETIC ASSOCIATION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MALE; OVERALL SURVIVAL; PROMOTER REGION; RETROPOSON; VALIDATION PROCESS; BRAIN; BRAIN TUMOR; GENETICS; MIDDLE AGED; PATHOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BRAIN; BRAIN NEOPLASMS; CPG ISLANDS; DNA METHYLATION; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC;

EID: 84896126312     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089376     Document Type: Article

References (46)

1. Baylin SB, Jones PA (2011) A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer 11: 726-734.
2. Christensen BC, Smith AA, Zheng S, Koestler DC, Houseman EA, et al. (2011) DNA methylation, isocitrate dehydrogenase mutation, and survival in glioma. J Natl Cancer Inst 103: 143-153.
3. Laffaire J, Everhard S, Idbaih A, Criniere E, Marie Y, et al. (2011) Methylation profiling identifies 2 groups of gliomas according to their tumorigenesis. Neuro Oncol 13: 84-98.
4. Martinez R, Martin-Subero JI, Rohde V, Kirsch M, Alaminos M, et al. (2009) A microarray-based DNA methylation study of glioblastoma multiforme. Epigenetics 4: 255-264.
5. Wu X, Rauch TA, Zhong X, Bennett WP, Latif F, et al. (2010) CpG island hypermethylation in human astrocytomas. Cancer Res 70: 2718-2727.
6. Noushmehr H, Weisenberger DJ, Diefes K, Phillips HS, Pujara K, et al. (2010) Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17: 510-522.
7. Hernandez DG, Nalls MA, Gibbs JR, Arepalli S, van der Brug M, et al. (2011) Distinct DNA methylation changes highly correlated with chronological age in the human brain. Hum Mol Genet 20: 1164-1172.
8. Ladd-Acosta C, Pevsner J, Sabunciyan S, Yolken RH, Webster MJ, et al. (2007) DNA methylation signatures within the human brain. Am J Hum Genet 81: 1304-1315. (Pubitemid 350211460)
9. Xin Y, Chanrion B, Liu MM, Galfalvy H, Costa R, et al. (2010) Genome-wide divergence of DNA methylation marks in cerebral and cerebellar cortices. PLoS One 5: e11357.
10. de Koning AP, Gu W, Castoe TA, Batzer MA, Pollock DD (2011) Repetitive elements may comprise over two-thirds of the human genome. PLoS Genet 7: e1002384.
11. Lee E, Iskow R, Yang L, Gokcumen O, Haseley P, et al. (2012) Landscape of somatic retrotransposition in human cancers. Science 337: 967-971.
12. Rodic N, Burns KH (2013) Long Interspersed Element-1 (LINE-1): Passenger or Driver in Human Neoplasms? PLoS Genet 9: e1003402.
13. Treangen TJ, Salzberg SL (2012) Repetitive DNA and next-generation sequencing: computational challenges and solutions. Nat Rev Genet 13: 36-46.
14. Ahn JB, Chung WB, Maeda O, Shin SJ, Kim HS, et al. (2011) DNA methylation predicts recurrence from resected stage III proximal colon cancer. Cancer 117: 1847-1854.
15. Ohka F, Natsume A, Motomura K, Kishida Y, Kondo Y, et al. (2011) The global DNA methylation surrogate LINE-1 methylation is correlated with MGMT promoter methylation and is a better prognostic factor for glioma. PLoS One 6: e23332.
16. Stricker I, Tzivras D, Nambiar S, Wulf J, Liffers ST, et al. (2012) Site- and grade-specific diversity of LINE1 methylation pattern in gastroenteropancreatic neuroendocrine tumours. Anticancer Res 32: 3699-3706.
17. Wang S, Dorsey TH, Terunuma A, Kittles RA, Ambs S, et al. (2012) Relationship between tumor DNA methylation status and patient characteristics in African-American and European-American women with breast cancer. PLoS One 7: e37928.
18. Woo HD, Kim J (2012) Global DNA hypomethylation in peripheral blood leukocytes as a biomarker for cancer risk: a meta-analysis. PLoS One 7: e34615.
19. Cadieux B, Ching TT, VandenBerg SR, Costello JF (2006) Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation. Cancer Res 66: 8469-8476. (Pubitemid 44449159)
20. Berman BP, Weisenberger DJ, Aman JF, Hinoue T, Ramjan Z, et al. (2012) Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina-associated domains. Nat Genet 44: 40-46.
21. Jin SG, Jiang Y, Qiu R, Rauch TA, Wang Y, et al. (2011) 5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations. Cancer Res 71: 7360-7365.
22. Gibbs JR, van der Brug MP, Hernandez DG, Traynor BJ, Nalls MA, et al. (2010) Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain. PLoS Genet 6: e1000952.
23. Bibikova M, Le J, Barnes B, Saedinia-Melnyk S, Zhou L, et al. (2009) Genome-wide DNA methylation profiling using Infinium(R) assay. Epigenomics 1: 177-200.
24. Quinlivan EP, Gregory JF 3rd (2008) DNA methylation determination by liquid chromatography-tandem mass spectrometry using novel biosynthetic [U-15N]deoxycytidine and [U-15N]methyldeoxycytidine internal standards. Nucleic Acids Res 36: e119.
25. Wu HC, Delgado-Cruzata L, Flom JD, Perrin M, Liao Y, et al. (2012) Repetitive element DNA methylation levels in white blood cell DNA from sisters discordant for breast cancer from the New York site of the Breast Cancer Family Registry. Carcinogenesis 33: 1946-1952.
26. Wu HC, Wang Q, Yang HI, Tsai WY, Chen CJ, et al. (2012) Global DNA methylation levels in white blood cells as a biomarker for hepatocellular carcinoma risk: a nested case-control study. Carcinogenesis 33: 1340-1345.
27. Zhang YJ, Wu HC, Yazici H, Yu MW, Lee PH, et al. (2012) Global hypomethylation in hepatocellular carcinoma and its relationship to aflatoxin B(1) exposure. World J Hepatol 4: 169-175.
28. Cykowski MD, Allen RA, Fung KM, Harmon MA, Dunn ST (2012) Pyrosequencing of IDH1 and IDH2 mutations in brain tumors and non-neoplastic conditions. Diagn Mol Pathol 21: 214-220.
29. Christians A, Hartmann C, Benner A, Meyer J, von Deimling A, et al. (2012) Prognostic value of three different methods of MGMT promoter methylation analysis in a prospective trial on newly diagnosed glioblastoma. PLoS One 7: e33449.
30. Havik AB, Brandal P, Honne H, Dahlback HS, Scheie D, et al. (2012) MGMT promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCR. J Transl Med 10: 36.
31. Shen J, Wang S, Zhang YJ, Kappil M, Wu HC, et al. (2012) Genome-wide DNA methylation profiles in hepatocellular carcinoma. Hepatology 55: 1799-1808.
32. Bady P, Sciuscio D, Diserens AC, Bloch J, van den Bent MJ, et al. (2012) MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status. Acta Neuropathol 124: 547-560.
33. Hansen KD, Timp W, Bravo HC, Sabunciyan S, Langmead B, et al. (2011) Increased methylation variation in epigenetic domains across cancer types. Nat Genet 43: 768-775.
34. Wang Y, Gu J, Roth JA, Hildebrandt MA, Lippman SM, et al. (2013) Pathway-based serum microRNA profiling and survival in patients with advanced stage non-small cell lung cancer. Cancer Res 73: 4801-4809.
35. Lee TI, Jenner RG, Boyer LA, Guenther MG, Levine SS, et al. (2006) Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 125: 301-313. (Pubitemid 44313811)
36. Sher F, Boddeke E, Olah M, Copray S (2012) Dynamic changes in Ezh2 gene occupancy underlie its involvement in neural stem cell self-renewal and differentiation towards oligodendrocytes. PLoS One 7: e40399.
37. Bert SA, Robinson MD, Strbenac D, Statham AL, Song JZ, et al. (2013) Regional activation of the cancer genome by long-range epigenetic remodeling. Cancer Cell 23: 9-22.
38. Hughes LA, Khalid-de Bakker CA, Smits KM, van den Brandt PA, Jonkers D, et al. (2012) The CpG island methylator phenotype in colorectal cancer: progress and problems. Biochim Biophys Acta 1825: 77-85.
39. Orzan F, Pellegatta S, Poliani PL, Pisati F, Caldera V, et al. (2011) Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells. Neuropathol Appl Neurobiol 37: 381-394.
40. Easwaran H, Johnstone SE, Van Neste L, Ohm J, Mosbruger T, et al. (2012) A DNA hypermethylation module for the stem/progenitor cell signature of cancer. Genome Res 22: 837-849.
41. Hegi ME, Liu L, Herman JG, Stupp R, Wick W, et al. (2008) Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity. J Clin Oncol 26: 4189-4199.
42. Rollins RA, Haghighi F, Edwards JR, Das R, Zhang MQ, et al. (2006) Large-scale structure of genomic methylation patterns. Genome Res 16: 157-163. (Pubitemid 43200263)
43. Branco MR, Ficz G, Reik W (2012) Uncovering the role of 5-hydroxymethylcytosine in the epigenome. Nat Rev Genet 13: 7-13.
44. Estecio MR, Gallegos J, Dekmezian M, Lu Y, Liang S, et al. (2012) SINE retrotransposons cause epigenetic reprogramming of adjacent gene promoters. Mol Cancer Res 10: 1332-1342.
45. Estecio MR, Gallegos J, Vallot C, Castoro RJ, Chung W, et al. (2010) Genome architecture marked by retrotransposons modulates predisposition to DNA methylation in cancer. Genome Res 20: 1369-1382.
46. Zhang Y, Shu J, Si J, Shen L, Estecio MR, et al. (2012) Repetitive elements and enforced transcriptional repression co-operate to enhance DNA methylation spreading into a promoter CpG-island. Nucleic Acids Res 40: 7257-7268.